Aerovate Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Aerovate Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aerovate Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aerovate Therapeutics by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $57k | 23k | 2.51 |
| 2024-12-31 | $36k | 14k | 2.65 |
| 2024-09-30 | $28k | 13k | 2.09 |
| 2024-06-30 | $25k | 15k | 1.66 |
| 2024-03-31 | $432k | 15k | 29.57 |
| 2023-12-31 | $320k | 14k | 22.63 |
| 2023-09-30 | $190k | 14k | 13.57 |
| 2023-06-30 | $223k | 13k | 17.15 |
| 2023-03-31 | $298k | 15k | 20.14 |
| 2022-12-31 | $417k | 14k | 29.30 |
| 2022-09-30 | $234k | 14k | 16.55 |
| 2022-06-30 | $206k | 13k | 15.61 |